GABAPENTIN
- Product NDC
- 43547-385
- 11-digit product format
- 435470385
- Labeler code
- 43547
- Product ID
- 43547-385_287538e6-6170-46b6-b209-6ae74b376b8a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Solco Healthcare U.S., LLC
- Application
- ANDA204989
- Marketing category
- ANDA
- Marketing start
- 2016-09-30
- Marketing end
- 2022-07-10
- Substance
- GABAPENTIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43547-385-03 | 43547038503 | 30 CAPSULE in 1 BOTTLE (43547-385-03) | 30 capsule | 2016-09-30 | 2022-07-10 | No | No | Current |
| 43547-385-10 | 43547038510 | 100 CAPSULE in 1 BOTTLE (43547-385-10) | 100 capsule | 2016-09-30 | 2022-07-10 | No | No | Current |
| 43547-385-50 | 43547038550 | 500 CAPSULE in 1 BOTTLE (43547-385-50) | 500 capsule | 2016-09-30 | 2022-07-10 | No | No | Current |